Benitec Biopharma Inc. (BNTC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:06PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.27M |
| Enterprise value | 5.02M |
| Trailing P/E | 51.55 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 35.88 |
| Price/book (mrq) | 2.87 |
| Enterprise value/revenue | 68.78 |
| Enterprise value/EBITDA | -0.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.25 |
| 52-week change 3 | -90.39% |
| S&P500 52-week change 3 | -13.66% |
| 52-week high 3 | 3.9000 |
| 52-week low 3 | 0.3010 |
| 50-day moving average 3 | 0.6903 |
| 200-day moving average 3 | 1.6117 |
Share statistics
| Avg vol (3-month) 3 | 304.08k |
| Avg vol (10-day) 3 | 187.18k |
| Shares outstanding 5 | 25.81M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 7.85M |
| % held by insiders 1 | 13.98% |
| % held by institutions 1 | 21.72% |
| Shares short (30 Aug 2022) 4 | 354.88k |
| Short ratio (30 Aug 2022) 4 | 3.92 |
| Short % of float (30 Aug 2022) 4 | 4.96% |
| Short % of shares outstanding (30 Aug 2022) 4 | 4.34% |
| Shares short (prior month 28 July 2022) 4 | 61.72k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 17 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:3 |
| Last split date 3 | 14 Apr 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 29 June 2022 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -24,457.53% |
Management effectiveness
| Return on assets (ttm) | -81.59% |
| Return on equity (ttm) | -159.08% |
Income statement
| Revenue (ttm) | 73k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -100.00% |
| Gross profit (ttm) | 64k |
| EBITDA | -17.69M |
| Net income avi to common (ttm) | -18.21M |
| Diluted EPS (ttm) | -2.1720 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.06M |
| Total cash per share (mrq) | 0.5 |
| Total debt (mrq) | 811k |
| Total debt/equity (mrq) | 28.14 |
| Current ratio (mrq) | 1.90 |
| Book value per share (mrq) | 0.35 |
Cash flow statement
| Operating cash flow (ttm) | -15.9M |
| Levered free cash flow (ttm) | -8.72M |
© 2022 Yahoo. All rights reserved.
